Nina Tandon, CEO and Co-founder of EpiBone, which is the world’s first company growing living human bones for skeletal reconstruction. She is also the co-author of Super Cells: Building with Biology, a book that explores the new frontier of biotech.

Epibone’s revolutionary, proprietary technology engineers stem cells into anatomically precise, patient specific bone tissue replacement.

Revolutionising medicine, her company is the first in the world to use a patient’s stem cells to grow human bone that can then be used to repair bone defects like bone loss.

EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to over 900,000 patients who undergo bone-related surgeries each year.

In 2013, she was awarded with Marie Claire third annual Women on Top Awards.